Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 111, 262-269
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (MOST 106-2314-B-371-005-MY3, 106-2314-B-371-006-MY3, 107-2314-B-371-008-MY3)
- Changhua Christian Hospital (107-CCH-HCR-046)
This publication has 24 references indexed in Scilit:
- Wogonin induces cross‐regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cellsJournal of Cellular Biochemistry, 2012
- ZJU-6, a novel derivative of Erianin, shows potent anti-tubulin polymerisation and anti-angiogenic activitiesInvestigational New Drugs, 2011
- Discovery of Isoerianin Analogues as Promising Anticancer AgentsChemMedChem, 2011
- Life and death by death receptorsThe FASEB Journal, 2009
- A new phenanthrene with a spirolactone from Dendrobium chrysanthum and its anti-inflammatory activitiesBioorganic & Medicinal Chemistry, 2006
- Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in TaiwanCancer Epidemiology, Biomarkers & Prevention, 2005
- The Pathophysiology of Mitochondrial Cell DeathScience, 2004
- In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agentEuropean Journal of Cancer, 2004
- Death Receptors: Signaling and ModulationScience, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997